These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30814658)

  • 1. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
    Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine (5-HT) receptor ligands.
    Kitson SL
    Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and Therapeutic Potential of the 5-HT
    Blattner KM; Canney DJ; Pippin DA; Blass BE
    ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
    Dukat M; Choi YN; Teitler M; Du Pre A; Herrick-Davis K; Smith C; Glennon RA
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1599-603. PubMed ID: 11412989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses.
    Wu N; Feng Z; He X; Kwon W; Wang J; Xie XQ
    Sci Rep; 2019 Feb; 9(1):2268. PubMed ID: 30783122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
    Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
    J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore models for metabotropic 5-HT receptor ligands.
    Bojarski AJ
    Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
    Doménech T; Beleta J; Palacios JM
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterisation of human 5-HT2 receptor subtypes.
    Jerman JC; Brough SJ; Gager T; Wood M; Coldwell MC; Smart D; Middlemiss DN
    Eur J Pharmacol; 2001 Feb; 414(1):23-30. PubMed ID: 11230991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment.
    Hietala J; Kuonnamäki M; Pälvimäki EP; Laakso A; Majasuo H; Syvälahti E
    Psychopharmacology (Berl); 2001 Sep; 157(2):180-7. PubMed ID: 11594443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of serotonin 5-HT
    Thirumaran SL; Lepailleur A; Rochais C
    Eur J Med Chem; 2019 Dec; 183():111705. PubMed ID: 31581003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR
    J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
    Dowd CS; Herrick-Davis K; Egan C; DuPre A; Smith C; Teitler M; Glennon RA
    J Med Chem; 2000 Aug; 43(16):3074-84. PubMed ID: 10956215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
    Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
    Molderings GJ; Frölich D; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest advances towards the discovery of 5-HT(7) receptor ligands.
    Pittala V; Pittala D
    Mini Rev Med Chem; 2011 Nov; 11(13):1108-21. PubMed ID: 22353220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.